new_0222_0489|KNTE|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0489|KNTE|1|Kinnate Biopharma Inc Total Current Assets (Quarterly) (USD)|Kinnate Biopharma Inc Cash and Short Term Investments (Quarterly) (USD)|Kinnate Biopharma Inc Inventories (Quarterly) (USD)|Kinnate Biopharma Inc Net PP&E (Quarterly) (USD)|Kinnate Biopharma Inc Goodwill and Intangibles (Quarterly) (USD)|Kinnate Biopharma Inc Total Liabilities (Quarterly) (USD)|Kinnate Biopharma Inc Total Current Liabilities (Quarterly) (USD)|Kinnate Biopharma Inc Total Long Term Liabilities (Quarterly) (USD)|Kinnate Biopharma Inc Total Deposits (Quarterly) (USD)|Kinnate Biopharma Inc Book Value (Quarterly) (USD)|Kinnate Biopharma Inc Retained Earnings (Quarterly) (USD)|Kinnate Biopharma Inc Treasury Stock (Quarterly) (USD)|Kinnate Biopharma Inc EV to Revenues|Kinnate Biopharma Inc EV to Earnings|Kinnate Biopharma Inc EV to Free Cash Flow|Kinnate Biopharma Inc EV to Assets (Quarterly)|Kinnate Biopharma Inc PS Ratio|Kinnate Biopharma Inc PE Ratio|Kinnate Biopharma Inc Price to Book Value|Kinnate Biopharma Inc PEG Ratio|Kinnate Biopharma Inc Debt to Equity Ratio|Kinnate Biopharma Inc Dividend Yield|Kinnate Biopharma Inc Shareholder Yield (TTM)|Kinnate Biopharma Inc Percent of Shares Outstanding Short|Kinnate Biopharma Inc Total Receivables (Quarterly) (USD)|Kinnate Biopharma Inc Total Payables (Quarterly) (USD)|Kinnate Biopharma Inc Total Capital Stock (Quarterly) (USD)|Kinnate Biopharma Inc Return on Invested Capital|Kinnate Biopharma Inc Quality Ratio Score|Kinnate Biopharma Inc Momentum Score|Kinnate Biopharma Inc Beta (1Y)|Kinnate Biopharma Inc Sustainable Growth Rate (TTM)|Kinnate Biopharma Inc Institutional Investor Ownership Percentage|Kinnate Biopharma Inc Average Diluted Shares Outstanding (Quarterly)|Kinnate Biopharma Inc Total Employees (Annual)|Kinnate Biopharma Inc EPS Diluted (Quarterly) (USD)|Kinnate Biopharma Inc Shares Outstanding|Kinnate Biopharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Kinnate Biopharma Inc Ordinary Shares Number (Quarterly)|Kinnate Biopharma Inc Payout Ratio|Kinnate Biopharma Inc Quick Ratio (Quarterly)|Kinnate Biopharma Inc Normalized Diluted EPS (Quarterly) (USD)|Kinnate Biopharma Inc Stock Buybacks (Quarterly) (USD)|Kinnate Biopharma Inc Effective Tax Rate (TTM)|Kinnate Biopharma Inc Return on Equity|Kinnate Biopharma Inc Net Income (TTM) (USD)|Kinnate Biopharma Inc Revenue (TTM) (USD)|Kinnate Biopharma Inc Dividend Per Share (Quarterly) (USD)|Kinnate Biopharma Inc Revenue (Quarterly) (USD)|Kinnate Biopharma Inc Gross Profit (Quarterly) (USD)|Kinnate Biopharma Inc SG&A Expense (Quarterly) (USD)|Kinnate Biopharma Inc Pre-Tax Income (Quarterly) (USD)|Kinnate Biopharma Inc Net Income (Quarterly) (USD)|Kinnate Biopharma Inc Net Interest Income (Quarterly) (USD)|Kinnate Biopharma Inc Price (USD)|Kinnate Biopharma Inc Total Return Price (USD)|Kinnate Biopharma Inc Enterprise Value (USD)|Kinnate Biopharma Inc 30-Day Average Daily Volume|Kinnate Biopharma Inc 1 Year Price Returns (Daily)||
new_0222_0489|KNTE|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0489|KNTE|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0489|KNTE|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||||1.44912280702||||1.44918032787|||1.45065789474||15.2592592593|183|127.8|127.8||||31|||91.2857142857|92|91.2857142857|31.0909090909||127.8|||91.2857142857|91.4|||91.25|||||91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.44918032787|1.44918032787|1.45065789474|1.44727272727|1.46153846154||
new_0222_0489|KNTE|6|5|5||5||5|5|5||5|5||||285||||305|||304||27|2|5|5||||1|||7|1|7|11||5|||7|5|||4|||||7|7|7|7|305|305|304|275|52||
new_0222_0489|KNTE|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0489|KNTE|201912|77.451|76.453||0.154||95.091|1.945|93.146||-17.486|-17.568||||||||||||||0.973|0.956||||||||23.2827||-0.1693|||41.0272|||-0.1693|||||||||0.926|-3.942|-3.942|0.043|||||||
new_0222_0489|KNTE|202003||||||||||||||||||||||||||||||||||23.2827||-0.1693||||||-0.1693|||||||||0.955|-3.941|-3.941|0.212|||||||
new_0222_0489|KNTE|202006||||||||||||||||||||||||||||||||||23.2827||-0.327||||||-0.327|||||||||2.047|-7.614|-7.614|0.012|||||||
new_0222_0489|KNTE|202009|157.479|156.859||0.316||6.699|6.699|||152.498|-39.622|0.075||||||||||||||2.328|0.003|||||||41.0272|27|-0.2559|||41.0272|||-0.2559||||-25.996|||||2.019|-10.499|-10.499|0.004|||||||
new_0222_0489|KNTE|202012|400.203|396.86||0.368||7.304|7.304|||393.267|-53.329||||-43.7257||||4.3979|||||1.2611||3.94|0.004|||||||43.4774|31|-0.3153|43.4774||43.4774|||-0.3153|-253.314|||-35.761|||||1.743|-13.707|-13.707|0.017|39.78|39.78|1332.671|158883.6||32.8|33.43
new_0222_0489|KNTE|202103|251.172|248.197||0.283||7.793|7.793|||378.572|-70.786||||-26.8445||||3.5786|||||3.3334||3.212|0.004|||||||43.4774||-0.4|43.4774||43.4774|||-0.4||||-49.277|||||4.815|-17.457|-17.457|0.403|31.16|31.16|1106.5588|321891.5333||26.82|23.48
new_0222_0489|KNTE|202106|258.78|220.008||0.286||43.323|8.323|35||361.34|-92.231||||-15.0389||||2.8105|||||3.5817||1.334|0.004|||||||43.5359||-0.49|43.6227||43.6227|||-0.49|-0.495|||-63.108|||||5.327|-21.445|-21.445|0.672|23.28|23.28|795.5285|128192.1333||21.58|22.12
new_0222_0489|KNTE|202109|260.712|223.228||0.291||45.299|10.299|35||341.03|-116.933||||-12.5529||||2.9486|||||4.5967||2.724|0.004|||||||43.664||-0.57|43.6827||43.6827|||-0.57||||-77.311|||||6.073|-24.702|-24.702|0.64|23.02|23.02|782.3478|198007.9||23.77|19.98
new_0222_0489|KNTE|202112|||||||||||||||-8.842||||2.2705|||||3.9612||||||2|0.2172||||||||||||||||||||||||17.72|17.72|551.0669|115861.9|-55.455|10.98|8.92